Metal cation-fluoroquinolone complexes do not permeate through the intestinal absorption barrier

Journal of Pharmaceutical and Biomedical Analysis

Volumn 53, Issue 3, 2010, Pages 655-659

  Simon, Žakelj ^a   Katja, Berginc ^a   Darko, Uršič ^a   Marjan, Veber ^a   Albin, Kristl ^a  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

Bioavailability; Chelation; Fluoroquinolone; Interaction; Metal cation; Permeability

Indexed keywords

ALUMINUM; CALCIUM ION; CIPROFLOXACIN; FERROUS ION; MAGNESIUM ION; NORFLOXACIN; OFLOXACIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DIFFUSION CHAMBER; DILUTION; DONOR; DRUG ABSORPTION; DRUG PENETRATION; IN VITRO STUDY; IN VIVO STUDY; INTESTINE ABSORPTION; INTESTINE MUCOSA; JEJUNUM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SOLUTION AND SOLUBILITY;

ALUMINUM; ANIMALS; ANTI-BACTERIAL AGENTS; FLUOROQUINOLONES; HYDROGEN-ION CONCENTRATION; INTESTINAL ABSORPTION; MALE; PERMEABILITY; RATS; RATS, WISTAR;

EID: 77954860340     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2010.05.021     Document Type: Article

References (31)

1. Höffken G., Borner K., Glatzel P.D., Koeppe P., Lode H. Reduced enteral absorption of ciprofloxacin in the presence of antacids. Eur. J. Clin. Microbiol. 1985, 4:345.
2. Lomaestro B.M., Bailie G.R. Absorption interactions with fluoroquinolones (1995 update). Drug Saf. 1995, 12:314-333.
3. Turel I. The interactions of metal ions with quinolone antibacterial agents. Coord. Chem. Rev. 2002, 232:27-47.
4. Žakelj S., Berginc K., Ursic D., Kristl A. Influence of metal cations on the solubility of fluoroquinolones. Pharmazie 2007, 62:318-320.
5. Mitscher L.A. Bacterial topoisomerase inhibitors: quinolone and pyridone antibacterial agents. Chem. Rev. 2005, 105:559-592.
6. Drevenšek P., Košmrlj J., Giester G., Skauge T., Sletten E., Sepčić K., Turel I. X-ray crystallographic, NMR and antimicrobial activity studies of magnesium complexes of fluoroquinolones - racemic ofloxacin and its S-form, levofloxacin. J. Inorg. Biochem. 2006, 100:1755-1763.
7. Yuk J.H., Nightingale C.H., Sweeney K.R., Quintiliani R., Lettieri J.T., Frost R.W. Relative bioavailability in healthy volunteers of ciprofloxacin administered through a nasogastric tube with and without enteral feeding. Antimicrob. Agents Chemother. 1998, 33:1118-1120.
8. Healy D.P., Brodbeck M.C., Clendening C.E. Ciprofloxacin absorption is impaired in patients given enteral feedings orally and via gastrostomy and jejunostomy tubes. Antimicrob. Agents Chemother. 1996, 40:6-10.
9. Tanaka M., Kurata T., Fujisawa C., Ohshima Y., Aoki H., Okazaki O., Hakusui H. Mechanistic study of inhibition of levofloxacin absorption by aluminum hydroxide. Antimicrob. Agents Chemother. 1993, 37:2173-2178.
10. Sánchez B.M., Martinez Cabarga M., Sánchez Navarro A., Dominguez-Gil Hurlé A. A physico-chemical study of the interaction of ciprofloxacin and ofloxacin with polyvalent cations. Int. J. Pharm. 1994, 106:229-235.
11. Ross D.L., Elkinton S.K., Knaub S.R., Riley C.M. Physicochemical properties of the fluoroquinolone antimicrobials. VI: Effects of metal-ion complexation on octan-1-ol-water partitioning. Int. J. Pharm. 1993, 93:131-138.
12. Kara M., Hasinoff B.B., McKay D.W., Campbell N.R. Clinical and chemical interactions between iron preparations and ciprofloxacin. Br. J. Clin. Pharmacol. 1991, 31:257-261.
13. Córdoba-Díaz M., Córdoba-Borrego M., Córdoba-Díaz D. Modification of fluorescent properties of norfloxacin in the presence of certain antacids. J. Pharm. Biomed. Anal. 1998, 18:565-571.
14. 2+ on absorption parameters of ciprofloxacin and ofloxacin. J. Antimicrob. Chemother. 1994, 34:119-125.
15. Kmetec V., Kozjek F., Veber M. Chromatographic and permeation analysis of ciprofloxacin metal complexes. Int. J. Pharm. 1999, 176:225-230.
16. Žakelj S., Šturm K., Kristl A. Ciprofloxacin permeability and its active secretion through rat small intestine in vitro. Int. J. Pharm. 2006, 313:175-180.
17. Žakelj S., Legen I., Veber M., Kristl A. The influence of buffer composition on tissue integrity during permeability experiments "in vitro" Int. J. Pharm. 2004, 272:173-180.
18. Söderholm J.D., Hedman L., Artursson P., Franzén L., Larsson J., Pantzar N., Permert J., Olaison G. Integrity and metabolism of human ileal mucosa in vitro in the Ussing chamber. Acta Physiol. Scand. 1998, 162:47-56.
19. Polentarutti B.I., Peterson A.L., Sjöberg A.K., Anderberg E.K., Utter L.M., Ungell A.L. Evaluation of viability of excised rat intestinal segments in the Ussing chamber: investigation of morphology, electrical parameters, and permeability characteristics. Pharm. Res. 1999, 16:446-454.
20. Center for Drug Evaluation and Research (CDER) Guidance for Industry: Waiver of In Vivo Bioavailability and Bioequivalence Studies for Immediate-Release Solid Oral Dosage Forms Based on a Biopharmaceutics Classification System, (2000) p. 13.
21. Skoog D.A., West D.M., Holler F.J., Crouch S.R. Fundamentals of Analytical Chemistry 1996, Saunders College Publishing, London, pp. A6-A7. seventh ed.
22. Ittel T.H., Kinzel S., Ortmanns A., Sieberth H.G. Effect of iron status on the intestinal absorption of aluminum: a reappraisal. Kidney Int. 1996, 50:1879-1888.
23. Nix D.E., Wilton J.H., Ronald B., Distlerath L., Williams V.C., Norman A. Inhibition of norfloxacin absorption by antacids. Antimicrob. Agents Chemother. 1990, 34:432-435.
24. Frost R.W., Lasseter K.C., Noe A.J., Shamblen E.C., Lettieri J.T. Effects of aluminum hydroxide and calcium carbonate antacids on the bioavailability of ciprofloxacin. Antimicrob. Agents Chemother. 1992, 36:830-832.
25. Amidon G.L., Sinko P.J., Fleisher D. Estimating human oral fraction dose absorbed: a correlation using rat intestinal membrane permeability for passive and carrier-mediated compounds. Pharm. Res. 1988, 5:651-654.
26. Nakano M., Yamamoto M., Arita T. Interactions of aluminium, magnesium and calcium ions with nalidixic acid. Chem. Pharm. Bull. 1978, 26:1505-1510.
27. Yokel R.A., McNamara P.J. Aluminium toxicokinetics: an updated minireview. Pharmacol. Toxicol. 2001, 88:159-167.
28. Shaikh A.R., Giridhar R., Yadav M.R. Bismuth-norfloxacin complex: synthesis, physicochemical and antimicrobial evaluation. Int. J. Pharm. 2007, 332:24-30.
29. Nix D.E., Watson W.A., Lener M.E., Frost R.W., Krol G., Goldstein H., Lettieri J., Schentag J.J. Effects of aluminum and magnesium antacids and ranitidine on the absorption of ciprofloxacin. Clin. Pharmacol. Ther. 1989, 46:700-705.
30. Polk R.E., Healy D.P., Sahai J., Drwal L., Racht E. Effect of ferrous sulfate and multivitamins with zinc on absorption of ciprofloxacin in normal volunteers. Antimicrob. Agents Chemother. 1989, 33:1841-1844.
31. Höffken G., Lode H., Wiley R., Glatzel T.D., Sievers D., Olschewski T., Borner K., Koeppe T. Pharmacokinetics and bioavailability of ciprofloxacin and ofloxacin: effect of food and antacid intake. Rev. Infect. Dis. 1988, 10:S138-S139.